Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19129670 | 0.98 | FUCA1 (0.35) | FUCA1 | |
| SCHEMBL16773473 | 0.98 | FUCA1 (0.35) | FUCA1 | |
| SCHEMBL26194052 | 0.98 | FUCA1 (0.35) | FUCA1 | |
| SCHEMBL14159315 | 0.85 | FUCA1 (0.37) | FUCA1CA9CA12CA2 | |
| SCHEMBL7996542 | 0.83 | FUCA1 (0.38) | FUCA1CA9CA12CA2 | |
| SCHEMBL21095319 | 0.80 | LGALS1 (0.34) | RPS6KA3 | |
| SCHEMBL21095314 | 0.80 | LGALS1 (0.34) | RPS6KA3 | |
| SCHEMBL21095312 | 0.80 | LGALS1 (0.34) | RPS6KA3 | |
| SCHEMBL21096133 | 0.80 | LGALS1 (0.34) | RPS6KA3 | |
| SCHEMBL12231786 | 0.80 | LGALS1 (0.34) | RPS6KA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9371351-B2 | Glycomimetics as Pseudomonas aeruginosa lectin inhibitors | Universität Konstanz (DE) | 2016-06-21 | — | — | US | disclosed |
| US-20150361122-A1 | Glycomimetics As Pseudomonas Aeruginosa Lectin Inhibitors | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361122-A1 | Glycomimetics As Pseudomonas Aeruginosa Lectin Inhibitors | FUCA1, ALG1, MUC1 | FUCA1 1/4885CA9 2411/4885CA12 1714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.